About Veeva Systems Inc. Class A Common Stock (VEEV)
Veeva Systems Inc is a leading provider of cloud-based software solutions tailored specifically for the global life sciences industry. The company offers a range of products designed to streamline and enhance various aspects of the pharmaceutical and biotech sectors, including research and development, regulatory compliance, and commercial operations. By leveraging advanced technology and data analytics, Veeva enables life sciences organizations to improve their efficiency, accelerate drug development processes, and ensure adherence to regulatory standards, ultimately contributing to better patient outcomes and innovation in healthcare. Read More
Shares of life sciences cloud software provider Veeva Systems (NYSE:VEEV) fell 3.8% in the morning session after its second-quarter earnings report failed to impress investors, even though the results beat expectations.
Life sciences cloud software provider Veeva Systems (NYSE:VEEV) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 16.7% year on year to $789.1 million. Guidance for next quarter’s revenue was better than expected at $791.5 million at the midpoint, 1.7% above analysts’ estimates. Its non-GAAP profit of $1.99 per share was 4.7% above analysts’ consensus estimates.
The stocks in this article are all trading near their 52-week highs.
This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.
Life sciences cloud software provider Veeva Systems (NYSE:VEEV) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 16.7% year on year to $789.1 million. Guidance for next quarter’s revenue was better than expected at $791.5 million at the midpoint, 1.7% above analysts’ estimates. Its non-GAAP profit of $1.99 per share was 4.7% above analysts’ consensus estimates.
Veeva Systems (VEEV) reported Q2 FY2026 earnings, beating revenue and EPS estimates. Despite strong growth in its life sciences cloud services, the stock declined in after-hours trading.
Wall Street traded cautiously on Wednesday, with major indices little changed at midday as investors awaited NVIDIA Corp.‘s (NASDAQ:NVDA) second-quarter earnings after the bell.
Life sciences cloud software provider Veeva Systems (NYSE:VEEV) will be reporting results this Wednesday after market close. Here’s what you need to know.
IQVIA (NYSE: IQV) and Veeva Systems (NYSE: VEEV) today announced global clinical and commercial partnerships and the complete resolution of all pending legal disputes. Under the terms of the long-term agreement, customers can use software, data, technology, and service offerings from Veeva and IQVIA together in a simple and efficient way.
Software is rapidly reducing operating expenses for businesses. Companies bringing it to life have been rewarded with high valuation multiples that make fundraising easier,
but they have weighed on the returns lately as the industry has pulled back by 11.5% over the past six months. This drop is a far cry from the S&P 500’s 5.2% ascent.
Veeva Systems has had an impressive run over the past six months as its shares have beaten the S&P 500 by 15.1%. The stock now trades at $282.13, marking a 20.4% gain. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Even if a company is profitable, it doesn’t always mean it’s a great investment.
Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
